Valeant Pharmaceuticals Intl Inchttps://investorshangout.com/Valeant-Pharmaceuticals-Intl-Inc-VRX-71264/en-usTue, 06 Oct 2026 02:41:13 GMTCopyright InvestorsHangout.comHedgeFunder: $VRX: RBC Capital Markets has $46.50 Price Target for Valeant Pharmaceuticals (VRX).https://investorshangout.com/post/view?id=4017101https://investorshangout.com/post/view?id=4017101Thu, 01 Sep 2016 02:56:18 GMTBloombergAnalyst: Hedge Funds Boost VRX Armstrong Henry H Associates Inc. boosted its position in Valeant Pharmaceuthttps://investorshangout.com/post/view?id=3518542https://investorshangout.com/post/view?id=3518542Mon, 01 Feb 2016 06:32:24 GMTBloombergAnalyst: Valeant Price Target $156.67 USD Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) hhttps://investorshangout.com/post/view?id=3517777https://investorshangout.com/post/view?id=3517777Sun, 31 Jan 2016 07:13:49 GMTBloombergAnalyst: VRX Expects Best Year Ever Here are three reasons why Valeant might just have its best year yet. 1https://investorshangout.com/post/view?id=3517773https://investorshangout.com/post/view?id=3517773Sun, 31 Jan 2016 07:11:36 GMTBloombergAnalyst: VRX PRICE EXPECTED TO DOUBLE IN A COMING BULLISH RALLY Valeant Pharmaceuticals turns Bullish https://investorshangout.com/post/view?id=3376438https://investorshangout.com/post/view?id=3376438Mon, 30 Nov 2015 17:38:52 GMT